logo
Tyra Biosciences up 3% as RA Capital increases stake to 22.4%

Tyra Biosciences up 3% as RA Capital increases stake to 22.4%

In a regulatory 13D/A filing, RA Capital disclosed that it has increased its stake in Tyra Biosciences (TYRA) to 22.4% from 20.1% reported in March. Shares were up 3% at $10.50 at the conclusion of the afterhours session.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BigBear.ai Stock (BBAI) Up 82% YTD, Technical Indicators Still Suggest 'Strong Buy'
BigBear.ai Stock (BBAI) Up 82% YTD, Technical Indicators Still Suggest 'Strong Buy'

Business Insider

time4 hours ago

  • Business Insider

BigBear.ai Stock (BBAI) Up 82% YTD, Technical Indicators Still Suggest 'Strong Buy'

(BBAI) shows growth potential given its expansion into commercial markets and AI vision tech through acquisitions. Also, the company has secured several key contracts, including one with the U.S. Department of Defense, boosting its reputation and financial standing. BBAI stock has soared 81.8% year-to-date. Despite these gains, technical indicators suggest that BBAI stock is a Strong Buy, implying further upside from current levels. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. BBAI is an AI-driven analytics company that provides decision intelligence solutions for defense, government, and commercial sectors. Analyzing Stock's Technical Indicators According to TipRanks' easy-to-understand technical analysis tool, BBAI stock is currently on an upward trend. The Moving Average Convergence Divergence (MACD) indicator, which helps understand momentum and potential price changes, signals a Buy. Further, the stock's 50-day Exponential Moving Average (EMA) is 5.21, while its price is $8.13, implying a bullish signal. Also, its shorter duration EMA (20 days) signals an uptrend. Another technical indicator, the Rate of Change (ROC), is a momentum-based technical indicator used to measure the percentage change in a stock's price between the current price and the price from a specific number of periods earlier. Typically, a ROC above zero confirms an uptrend. BBAI stock currently has an ROC of 48.02, which signals a Buy. Is BBAI Stock a Good Buy? Turning to Wall Street, BBAI stock has a Moderate Buy consensus rating based on two Buys and two Holds assigned in the last three months. At $5.83, the average price target implies 28.4% downside potential.

Morgan Stanley Remains a Hold on Qube Holdings (1K1)
Morgan Stanley Remains a Hold on Qube Holdings (1K1)

Business Insider

time5 hours ago

  • Business Insider

Morgan Stanley Remains a Hold on Qube Holdings (1K1)

Morgan Stanley analyst Robert Koh maintained a Hold rating on Qube Holdings today and set a price target of A$4.20. The company's shares closed last Tuesday at €2.36. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Koh is a 3-star analyst with an average return of 2.3% and a 52.05% success rate. Koh covers the Energy sector, focusing on stocks such as Origin Energy Limited, Ampol Limited, and Santos Limited. Qube Holdings has an analyst consensus of Moderate Buy, with a price target consensus of €2.51, representing a 6.36% upside. In a report released on July 14, RBC Capital also maintained a Hold rating on the stock with a A$4.30 price target. 1K1 market cap is currently €4.2B and has a P/E ratio of 30.69.

Ord Minnett Sticks to Its Buy Rating for BlueBet Holdings Ltd. (BBT)
Ord Minnett Sticks to Its Buy Rating for BlueBet Holdings Ltd. (BBT)

Business Insider

time5 hours ago

  • Business Insider

Ord Minnett Sticks to Its Buy Rating for BlueBet Holdings Ltd. (BBT)

In a report released today, Phillip Chippindale from Ord Minnett maintained a Buy rating on BlueBet Holdings Ltd., with a price target of A$0.46. The company's shares opened today at A$0.31. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Chippindale is an analyst with an average return of -0.8% and a 39.01% success rate. The word on The Street in general, suggests a Strong Buy analyst consensus rating for BlueBet Holdings Ltd. with a A$0.47 average price target.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store